Featured Research

from universities, journals, and other organizations

Color vision problems become more common with age, study shows

Date:
February 20, 2014
Source:
Wolters Kluwer Health: Lippincott Williams & Wilkins
Summary:
Abnormal color vision increases significantly with aging -— affecting one-half or more of people in the oldest age groups, reports a study. While few people younger than 70 have problems with color vision, the rate increases rapidly through later decades of life, with the majority of problems encountered with the blue-yellow colors.

Abnormal color vision increases significantly with aging -- affecting one-half or more of people in the oldest age groups, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

While few people younger than 70 have problems with color vision, the rate increases rapidly through later decades of life, according to the new research by Marilyn E. Schneck, PhD, and colleagues of The Smith-Kettlewell Eye Research Institute, San Francisco. They write, "We find the color discrimination declines with age and that the majority of color defects among the older population are of the blue-yellow type."

Color Vision Abnormalities Increase with Age

The researchers administered color vision tests to a random sample of 865 older adults -- age range 58 to 102 years. The study excluded subjects with any type of congenital color-vision defect ("color blindness."). The types and rates of color vision abnormalities were assessed in different age groups.

Overall, 40 percent of the participants had abnormal results on one of the two color vision tests used in the study. Twenty percent failed both tests.

The failure rate was markedly higher in older age groups. Although color-vision abnormalities were uncommon in people younger than 70, they were present in about 45 percent of people in their mid-70s, up to 50 percent of those 85 and older, and nearly two-thirds of those in their mid-90s.

Nearly 80 percent of the abnormalities involved confusion of the lighter (pastel) shades of blue versus purple and yellow versus green and yellow-green. These "blue-yellow" errors are distinct from the "red-green" errors observed in people with inherited color blindness, which affects about eight percent of males and 0.5 percent of females. Although the two tests had different failure rates, they detected similar frequencies of blue-yellow errors.

More Severe Defects May Affect Daily Functioning

The results confirm previous studies showing that color vision "deteriorates measurably" with aging. Most subtle aging-related color vision abnormalities are likely to go unnoticed, the researchers suggest.

However, they note that nearly 20 percent of older adults failed the easier of the two tests, "designed to only detect defects sufficiently severe to affect performance in daily life." Dr Schneck and coauthors note, "These individuals would have problems carrying out some tasks that rely on color vision."

The researchers discuss factors that may contribute to changes in color vision with aging, and to blue-yellow defects in particular. These may include reduced pupil size, admitting less light into the eye; increased yellowing of the lens inside the eye; and changes in the sensitivity of the vision pathways. All of these are known changes with age to the human eye.

Increased rates of eye diseases are another potentially important contributor. Dr Schneck and coauthors add, "The most common age-related eye diseases (glaucoma, age-related macular degeneration, and diabetic eye disease) all produce blue-yellow color vision anomalies, at least in the preclinical or early stages."


Story Source:

The above story is based on materials provided by Wolters Kluwer Health: Lippincott Williams & Wilkins. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gunilla Haegerstrom-Portnoy, Marilyn E. Schneck, Lori A. Lott, Susan E. Hewlett, John A. Brabyn. Longitudinal Increase in Anisometropia in Older Adults. Optometry and Vision Science, 2014; 91 (1): 60 DOI: 10.1097/OPX.0000000000000114

Cite This Page:

Wolters Kluwer Health: Lippincott Williams & Wilkins. "Color vision problems become more common with age, study shows." ScienceDaily. ScienceDaily, 20 February 2014. <www.sciencedaily.com/releases/2014/02/140220102614.htm>.
Wolters Kluwer Health: Lippincott Williams & Wilkins. (2014, February 20). Color vision problems become more common with age, study shows. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140220102614.htm
Wolters Kluwer Health: Lippincott Williams & Wilkins. "Color vision problems become more common with age, study shows." ScienceDaily. www.sciencedaily.com/releases/2014/02/140220102614.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins